M Ventures


M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, focused on investing in Biotechnology and Technology. The firm targets areas such as Healthcare drug development, Life Science tools, Electronics, and Frontier Technology & Sustainability. M Ventures aims to invest in visionary companies that address challenging diseases, empower scientific research, and develop innovative solutions for information processing and sustainability. The firm takes an active role in its portfolio companies, collaborating with entrepreneurs and co-investors to drive innovation towards commercial success.

M Ventures

M Ventures

Eduard van Beinumstraat 26, 1077 CZ Amsterdam, The Netherlands


Portfolio

ImmuneBridge is developing allogeneic immunotherapies for cancer.

#Biotechnology

Tignis provides AI and ML data science solutions for semiconductor equipment manufacturers.

#Technology

Outrun Therapeutics is an E3 ligase inhibitor company focused on cancer therapeutics.

#Biotechnology

MemryX designs and sells innovative Edge AI processors.

#Technology

Calypso Biotech develops monoclonal antibodies for immune pathologies.

#Biotechnology

beeOLED is focused on developing efficient and stable deep-blue emitters for OLED displays.

#Technology